The U.S. Justice Department plans to intervene in lawsuits accusing North Chicago, Ill.-based Abbott Laboratories of off-label marketing for its drug, Depakote, according to a Chicago Tribune report.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback